Increased systemic inflammation and oxidative stress in patients with worsening congestive heart failure: improvement after short-term inotropic supportMichel White, Rhian M. Touyz, Ernesto L. Schiffrin et al.|Clinical Science|2006Cited by 100
Effects of Combined Candesartan and ACE Inhibitors on BNP, Markers of Inflammation and Oxidative Stress, and Glucose Regulation in Patients With Symptomatic Heart FailureMichel White, Rhian M. Touyz, Serge Lepage et al.|Journal of Cardiac Failure|2007Cited by 47
Effects of AGTR1 A1166C Gene Polymorphism in Patients with Heart Failure Treated with CandesartanSimon de Denus, Michel White, Marcin Zakrzewski‐Jakubiak et al.|Annals of Pharmacotherapy|2008Cited by 41
Effects of Angiotensin-Converting Enzyme Inhibitor Versus Valsartan on Cellular Signaling Events in Heart TransplantMichel White, Laure Voisin, Heather J. Ross et al.|Annals of Pharmacotherapy|2009Cited by 2
1012-129 Dual angiotensin-II suppression with angiotensin-converting enzyme inhibitor and irbesartan improves submaximal exercise time without changes in exercise-induced neurohumoral response in patients with congestive heart failureMartine Blanchet, Michel White, Richard Sheppard et al.|Journal of the American College of Cardiology|2004Cited by 1